1. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis;Dunaif;Endocrine Rev,1997
2. The insulin sensitising agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovarian syndrome;Dunaif;J Clin Endocrinol Metab,1996
3. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome;Ehrmann;J Clin Endocrinol Metab,1997
4. Decrease in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome;Nestler;N Engl J Med,1996
5. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, hyperandrogenemia and systolic blood pressure, while facilitating normal menses and pregnancy;Velazquez;Metabolism,1994